Exelixis
EXEL
#1573
Rank
NZ$19.20 B
Marketcap
$68.36
Share price
-0.19%
Change (1 day)
85.04%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company